Cho Tang
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 5
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 5
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 8
- Cancer therapeutics and mechanisms 4
- Chemical Synthesis and Analysis 3
- Protein Tyrosine Phosphatases 3
- Oncology top 2%
- HER2/EGFR in Cancer Research 4
- Organic Chemistry top 2%
- Synthesis and Reactions of Organic Compounds 3
- Co-authors
- Gerald McMahonLi SunPeter HirthStevan R. HubbardJoseph SchlessingerMoosa MohammadiFlora TangBrian Yeh
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesSwedenJapan
In The Last Decade
Cho Tang
29 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 704
- Toxicology 146
- Molecular Biology 2.9k
- Oncology 1.0k
- Organic Chemistry 816
Countries citing papers authored by Cho Tang
This map shows the geographic impact of Cho Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cho Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cho Tang more than expected).
Fields of papers citing papers by Cho Tang
This network shows the impact of papers produced by Cho Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cho Tang. The network helps show where Cho Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cho Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 15 | |
| 2 | 2006 | 20 | |
| 3 | 2006 | 69 | |
| 4 | 2004 | 1 | |
| 5 | 2003 | 51 | |
| 6 | 2003 | 22 | |
| 7 | 2003 | 63 | |
| 8 | 2003 | 45 | |
| 9 | 2003 | 32 | |
| 10 | 2002 | 20 | |
| 11 | 2002 | 1 | |
| 12 | 2000 | 99 | |
| 13 | 1999 | 34 | |
| 14 | SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.breakdown → | 1999 | 885 |
| 15 | 1999 | 39 | |
| 16 | Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitorsbreakdown → | 1997 | 960 |
| 17 | 1992 | 6 | |
| 18 | 1988 | 14 | |
| 19 | 1987 | 31 | |
| 20 | 1979 | 7 |
About Cho Tang
Cho Tang is a scholar working on Toxicology, Biological Psychiatry, Molecular Biology, Cancer Research and Organic Chemistry, having authored 29 papers that have together received 4.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (4 papers), Chemical Synthesis and Analysis (3 papers), Protein Tyrosine Phosphatases (3 papers) and Synthesis and Reactions of Organic Compounds (3 papers). The work is most often cited by research in Cancer Research (704 citations), Toxicology (146 citations), Molecular Biology (2.9k citations), Oncology (1.0k citations) and Organic Chemistry (816 citations). Cho Tang has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Gerald McMahon, Li Sun, Peter Hirth, Stevan R. Hubbard, Joseph Schlessinger, Moosa Mohammadi, Flora Tang, Brian Yeh, Laura K. Shawver and Randall Schreck. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Organic Letters and British Journal of Anaesthesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.